Today: 10 June 2026
Browse Category

NASDAQ:PTGX 10 October 2025 - 11 October 2025

Protagonist Therapeutics: Small Biotech Skyrockets on Buyout Buzz & Breakthrough Trials

Protagonist Therapeutics: Small Biotech Skyrockets on Buyout Buzz & Breakthrough Trials

Protagonist Therapeutics shares surged over 30% to nearly $89 on October 10, 2025, after reports that Johnson & Johnson is in talks to acquire the company. Trading was briefly halted due to volatility. The company, valued at about $5.4 billion, recently announced positive trial results for its lead drugs and secured major partnerships with J&J and Takeda.
11 October 2025
·····
Protagonist Therapeutics (PTGX) Skyrockets on J&J Buyout Buzz Amid Clinical Breakthroughs

Protagonist Therapeutics (PTGX) Skyrockets on J&J Buyout Buzz Amid Clinical Breakthroughs

Protagonist Therapeutics shares surged over 30% to $89.19 on Oct. 10, 2025, after reports that Johnson & Johnson is in talks to acquire the company. Trading was briefly halted due to volatility. The jump follows positive Phase 2b results for Icotrokinra in ulcerative colitis and recent FDA Breakthrough Therapy Designation for Rusfertide in polycythemia vera.
10 October 2025
···

Stock Market Today

  • CMC Markets Executives Buy Shares Under UK Incentive Plan
    June 10, 2026, 7:31 AM EDT. CMC Markets senior executives David John Fineberg and Jonathan Bendall each acquired 64 shares at 464.50p under the company's UK Share Incentive Plan on June 5, 2026. These routine transactions highlight the firm's use of equity-based compensation to align management interests with shareholders and maintain talent retention. CMC Markets, a UK online trading platform operator, currently holds a market capitalization of £1.3 billion. Analyst sentiment remains positive, with a Buy rating and a £500 price target, supported by strong financial performance and a robust balance sheet despite some cash-flow volatility. The stock shows a clear uptrend but faces near-term risks from overbought technical indicators.

Latest articles

Coupang (CPNG) Gains Ahead of South Korea Privacy Fine Ruling

Coupang (CPNG) Gains Ahead of South Korea Privacy Fine Ruling

10 June 2026
Coupang shares jumped 4.68% to $15.90 as investors await a South Korean privacy ruling that could fine the company up to 1.36 trillion won over a breach affecting 33 million records; the commission’s decision, expected as soon as Thursday, will determine the true financial impact and next move for the stock.
Apple Shares Slip After WWDC, Siri AI Plans Leave Upgrade Path Unclear

Apple Shares Slip After WWDC, Siri AI Plans Leave Upgrade Path Unclear

10 June 2026
Apple shares fell $11.01 to $290.55 after WWDC as investors reacted to Siri AI’s delayed, English-only beta launch, strict device limits, and lack of immediate iPhone demand boost, with Morgan Stanley warning over 1.3 billion iPhones can’t access advanced features and regional rollout hurdles in the EU and China raising doubts about a global upgrade cycle.
Hitek Global Rallies Before Hours as Traders Watch HKIT $8 Million Offer

Hitek Global Rallies Before Hours as Traders Watch HKIT $8 Million Offer

10 June 2026
HKIT plunged 13.25% to $0.273 Tuesday on volume six times its average, then rebounded to $0.428 premarket as traders digested a recent $8 million direct offering with warrants that could trigger major dilution; Hitek warned that new shares from these warrants could pressure the stock price and threaten Nasdaq listing if prices stay below $1.
ChowChow Cloud Stock Jumps Premarket as CHOW Volume Explodes Again

ChowChow Cloud Stock Jumps Premarket as CHOW Volume Explodes Again

10 June 2026
ChowChow Cloud (CHOW) soared over 200% premarket on massive volume, despite no new operating update and ongoing net losses, negative cash flow, and pending shareholder litigation, highlighting extreme volatility and risk for investors as the stock trades far below its IPO price.
Go toTop